B-RAF with PLX4032

From Proteopedia
Revision as of 16:06, 6 October 2010 by J.D. Woodruff (talk | contribs)
Jump to navigation Jump to search

B-RAF with PLX4032B-RAF with PLX4032

PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.











testcaption

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Jens Hemmingsen, J.D. Woodruff, Michal Harel